首页> 美国卫生研究院文献>Heliyon >Probing nanoliposomes using single particle analytical techniques: effect of excipients solvents phase transition and zeta potential
【2h】

Probing nanoliposomes using single particle analytical techniques: effect of excipients solvents phase transition and zeta potential

机译:使用单颗粒分析技术探测纳米脂质体:赋形剂溶剂相变和ζ电势的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

There has been a steady increase in the interest towards employing nanoliposomes as colloidal drug delivery systems, particularly in the last few years. Their biocompatibility nature along with the possibility of encapsulation of lipid-soluble, water-soluble and amphipathic molecules and compounds are among the advantages of employing these lipidic nanocarriers. A challenge in the successful formulation of nanoliposomal systems is to control the critical physicochemical properties, which impact their in vivo performance, and validating analytical techniques that can adequately characterize these nanostructures. Of particular interest are the chemical composition of nanoliposomes, their phase transition temperature, state of the encapsulated material, encapsulation efficiency, particle size distribution, morphology, internal structure, lamellarity, surface charge, and drug release pattern. These attributes are highly important in revealing the supramolecular arrangement of nanoliposomes and incorporated drugs and ensuring the stability of the formulation as well as consistent drug delivery to target tissues. In this article, we present characterization of nanoliposomal formulations as an example to illustrate identification of key in vitro characteristics of a typical nanotherapeutic agent. Corresponding analytical techniques are discussed within the context of nanoliposome assessment, single particle analysis and ensuring uniform manufacture of therapeutic formulations with batch-to-batch consistency.
机译:对于使用纳米脂质体作为胶体药物递送系统的兴趣一直在稳定增长,特别是在最近几年中。它们的生物相容性以及包封脂溶性,水溶性和两亲性分子和化合物的可能性是使用这些脂质纳米载体的优点之一。成功配制纳米脂质体系统的一个挑战是控制影响其体内性能的关键物理化学性质,并验证可以充分表征这些纳米结构的分析技术。特别令人感兴趣的是纳米脂质体的化学组成,其相变温度,被包封的材料的状态,包封效率,粒度分布,形态,内部结构,层状性,表面电荷和药物释放模式。这些属性在揭示纳米脂质体和掺入药物的超分子排列以及确保制剂的稳定性以及向靶组织的一致药物递送中非常重要。在本文中,我们以纳米脂质体制剂的表征为例,以举例说明典型纳米治疗剂体外关键特性的鉴定。在纳米脂质体评估,单颗粒分析以及确保批次间一致性的治疗性制剂的统一生产中讨论了相应的分析技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号